“Don’t Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer’s disease and other tauopathies
Yuxing Xia, Stefan Prokop, Benoit I. Giasson · Molecular Neurodegeneration · 2021 · Review
Full textCC BY